表紙
市場調查報告書

非侵入性血糖監測系統的全球市場:2019年∼2023年

Non-invasive Glucose Monitoring Devices Market by Product and Geography - Global Forecast and Analysis 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 910733
出版日期 內容資訊 英文 127 Pages
訂單完成後即時交付
價格
非侵入性血糖監測系統的全球市場:2019年∼2023年 Non-invasive Glucose Monitoring Devices Market by Product and Geography - Global Forecast and Analysis 2019-2023
出版日期: 2019年09月06日內容資訊: 英文 127 Pages
簡介

非侵入性血糖監測系統設備市場上,糖尿病的盛行率的增加和政府計劃的增加,產品的發表,非侵入性治療的需求的增加等成為成長促進因素,在預測期間內預計將以11%以上的年複合成長率擴大。但,由於準確度的問題造成產品撤出市場,非侵入性血糖監測系統相關的高成本,傳統的血糖儀的激烈競爭與強烈存在感等要素,可能妨礙在預測期間內非侵入性血糖監測系統產業的成長。

本報告提供全球非侵入性血糖監測系統市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2018年∼2023年)
  • 隨身裝置
  • 非隨身裝置
  • 市場機會:各產品

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 為擴大產業對合作的關注高漲
  • 血糖監測系統的AI和RADAR技術的整合
  • 對非侵入性血糖監測系統技術的財政支援的增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott Laboratories
  • Cnoga Medical Ltd.
  • Evia Medical Technologies
  • Helo Corp.
  • Integrity Applications Inc.
  • Nemaura Medical Inc.
  • RISE Life Science Corp.
  • Taiwan Biophotonic Co.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR32011

About this market

Technavio's non-invasive glucose monitoring devices market analysis considers sales from products such as wearable devices and non-wearable devices. Our analysis also considers the sales of non-invasive glucose monitoring devices in Asia, Europe, North America, and ROW. In 2018, the wearable devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of diabetes, technological advancements, and new product launches will play a significant role in the wearable devices segment to maintain its market position. Also, our global non-invasive glucose monitoring devices market report looks at factors such as increasing prevalence of diabetes and growing number of government programs, product launches and increasing demand for non-invasive procedures. However, product withdrawal from the market due to accuracy issues, high costs associated with non-invasive glucose monitoring devices, and intense competition and strong presence of conventional blood glucometer may hamper the growth of the non-invasive glucose monitoring devices industry over the forecast period.

Overview

Increasing demand for non-invasive procedures

The demand for non-invasive monitoring and diagnostic procedures is increasing owing to their ease of operation, fewer side effects and minimum discomfort. Non-invasive glucose monitoring devices are increasingly being used as alternatives to conventional blood glucose monitoring devices as the latter method causes pain and discomfort to patients. Moreover, it provides real-time data that shows trends in glucose measurements and help in maintaining a standard glucose level by controlling diabetes and complications associated with it. This will lead to the expansion of the global non-invasive glucose monitoring devices market at a CAGR of over 11% during the forecast period.

Integration of AI and RADAR technology in glucose monitoring

The integration of AI and RADAR systems in diagnostic devices has revolutionized the medical industry. This has led the researcher to develop non-invasive glucose monitoring devices combining AI and RADAR technologies, which enables people with diabetes to monitor their blood glucose levels. Vendors are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Such technologies will eliminate the need for finger pricking. The integration of data received from digital medical devices with mobile applications allow customers to easily monitor body parameters, such as changes in glucose levels. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global non-invasive glucose monitoring devices market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global non-invasive glucose monitoring devices market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices manufacturers, that include Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.

Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Wearable devices - Market size and forecast 2018-2023
  • Non-wearable devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing focus on collaborations for business expansion
  • Integration of AI and RADAR technology in glucose monitoring
  • Growing funding for non-invasive glucose monitoring technology

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Cnoga Medical Ltd.
  • Evia Medical Technologies
  • Helo Corp.
  • Integrity Applications Inc.
  • Nemaura Medical Inc.
  • RISE Life Science Corp.
  • Taiwan Biophotonic Co.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product Overview
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Wearable devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Wearable devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Non-wearable devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Non-wearable devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2018-2023 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Abbott Laboratories - Vendor overview
  • Exhibit 45: Abbott Laboratories - Business segments
  • Exhibit 46: Abbott Laboratories - Organizational developments
  • Exhibit 47: Abbott Laboratories - Geographic focus
  • Exhibit 48: Abbott Laboratories - Segment focus
  • Exhibit 49: Abbott Laboratories - Key offerings
  • Exhibit 50: Abbott Laboratories - Key customers
  • Exhibit 51: Cnoga Medical Ltd. - Vendor overview
  • Exhibit 52: Cnoga Medical Ltd. - Key offerings
  • Exhibit 53: Cnoga Medical Ltd. - Key customers
  • Exhibit 54: Evia Medical Technologies - Vendor overview
  • Exhibit 55: Evia Medical Technologies - Business segments
  • Exhibit 56: Evia Medical Technologies - Key offerings
  • Exhibit 57: Evia Medical Technologies - Key customers
  • Exhibit 58: Helo Corp. - Vendor overview
  • Exhibit 59: Helo Corp. - Key offerings
  • Exhibit 60: Helo Corp. - Key customers
  • Exhibit 61: Integrity Applications Inc. - Vendor overview
  • Exhibit 62: Integrity Applications Inc. - Organizational developments
  • Exhibit 63: Integrity Applications Inc. - Geographic focus
  • Exhibit 64: Integrity Applications Inc. - Key offerings
  • Exhibit 65: Integrity Applications Inc. - Key customers
  • Exhibit 66: Nemaura Medical Inc. - Vendor overview
  • Exhibit 67: Nemaura Medical Inc. - Organizational developments
  • Exhibit 68: Nemaura Medical Inc. - Key offerings
  • Exhibit 69: Nemaura Medical Inc. - Key customers
  • Exhibit 70: RISE Life Science Corp. - Vendor overview
  • Exhibit 71: RISE Life Science Corp. - Business segments
  • Exhibit 72: RISE Life Science Corp. - Organizational developments
  • Exhibit 73: RISE Life Science Corp. - Key offerings
  • Exhibit 74: RISE Life Science Corp. - Key customers
  • Exhibit 75: Taiwan Biophotonic Co. - Vendor overview
  • Exhibit 76: Taiwan Biophotonic Co. - Organizational developments
  • Exhibit 77: Taiwan Biophotonic Co. - Key offerings
  • Exhibit 78: Taiwan Biophotonic Co. - Key customers
  • Exhibit 79: Validation techniques employed for market sizing
  • Exhibit 80: Definition of market positioning of vendors